InvestorsHub Logo

tkg

Followers 30
Posts 2031
Boards Moderated 0
Alias Born 07/17/2013

tkg

Re: x993231 post# 80226

Sunday, 09/19/2021 5:28:55 AM

Sunday, September 19, 2021 5:28:55 AM

Post# of 201449

"Pharmasset, before it got acquired, had only 80 employees with no commercial products yet available. At first, Gilead offered $100 per share. However, Pharmasset considered it inadequate, and Pharmasset's CEO revealed to Gilead that it would deliver important information about its positive development at the American Association for the Study of Liver Diseases. If the positive product development information would be released to the market, Pharmasset's share price would surge higher, making the acquisition more expensive for Gilead. At last, the final price tag was as high as $137 per share, making the total acquisition price of $11 billion. Fast-forward four years later, this acquisition seems to be quite successful. Pharmasset's acquisition has brought Gilead the foundation for Sovaldi and Harvoni. Both Sovaldi and Harvoni have significantly increased the business performance of Gilead. In 2014 alone, Sovaldi generated nearly $10.3 billion in revenue, accounting for nearly 45.9% of Gilead's total revenue. For the full year 2015, Gilead expected to generate $32.1 billion in sales, a 31.4% year-over-year growth.


Substitute Lightwave Logic and a company Like Amazon/Facebook/Apple/Netfix or Google taking them over. "

What a great analogy Xster!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LWLG News